Eli Historical Financial Ratios
LLY Stock | USD 737.20 3.69 0.50% |
Eli Lilly is recently reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 61.94 will help investors to properly organize and evaluate Eli Lilly financial condition quickly.
Eli |
About Eli Financial Ratios Analysis
Eli LillyFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Eli Lilly investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Eli financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Eli Lilly history.
Eli Lilly Financial Ratios Chart
Eli Lilly and financial ratios usually calculated using numerical values taken directly from Eli Lilly financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Eli Lilly. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Eli Lilly's POCF Ratio is fairly stable compared to the past year. Payout Ratio is likely to rise to 0.82 in 2024, whereas Dividend Yield is likely to drop 0.01 in 2024. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Eli Lilly stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Eli Lilly sales, a figure that is much harder to manipulate than other Eli Lilly and multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Eli Lilly and dividend as a percentage of Eli Lilly stock price. Eli Lilly dividend yield is a measure of Eli Lilly stock productivity, which can be interpreted as interest rate earned on an Eli Lilly investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Eli Lilly's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Eli Lilly current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Eli Lilly's POCF Ratio is fairly stable compared to the past year. Payout Ratio is likely to rise to 0.82 in 2024, whereas Dividend Yield is likely to drop 0.01 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0123 | 0.0107 | 0.007755 | 0.007367 | Price To Sales Ratio | 8.85 | 11.56 | 15.38 | 16.15 |
Eli Lilly fundamentals Correlations
Click cells to compare fundamentals
Eli Lilly Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Eli Lilly fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 5.48 | 6.24 | 8.85 | 11.56 | 15.38 | 16.15 | |
Ptb Ratio | 46.94 | 27.16 | 27.9 | 30.98 | 48.71 | 51.15 | |
Days Sales Outstanding | 90.62 | 103.06 | 104.75 | 109.45 | 121.25 | 61.94 | |
Book Value Per Share | 2.8 | 6.22 | 9.9 | 11.81 | 11.97 | 6.16 | |
Free Cash Flow Yield | 0.0285 | 0.0292 | 0.0215 | 0.0139 | (0.006007) | (0.005707) | |
Invested Capital | 6.06 | 2.94 | 1.88 | 1.52 | 2.34 | 2.46 | |
Operating Cash Flow Per Share | 5.19 | 7.16 | 8.01 | 7.86 | 4.71 | 2.99 | |
Capex To Depreciation | (1.1) | (1.53) | (1.21) | (1.63) | (4.84) | (4.6) | |
Pb Ratio | 46.94 | 27.16 | 27.9 | 30.98 | 48.71 | 51.15 | |
Ev To Sales | 6.09 | 6.77 | 9.31 | 12.05 | 16.03 | 16.84 | |
Free Cash Flow Per Share | 3.74 | 4.93 | 5.94 | 5.1 | (3.5) | (3.33) | |
Inventory Turnover | 1.48 | 1.38 | 1.88 | 1.54 | 1.14 | 1.83 | |
Net Income Per Share | 4.98 | 6.82 | 6.15 | 6.93 | 5.82 | 6.11 | |
Days Of Inventory On Hand | 246.68 | 264.95 | 193.96 | 237.27 | 320.42 | 180.07 | |
Payables Turnover | 3.88 | 3.36 | 3.41 | 3.43 | 2.53 | 2.99 | |
Capex To Revenue | (0.0606) | (0.0827) | (0.0661) | (0.087) | (0.22) | (0.21) | |
Cash Per Share | 2.62 | 4.06 | 4.31 | 2.45 | 3.25 | 2.56 | |
Pocfratio | 25.3 | 23.58 | 34.5 | 46.57 | 123.75 | 129.94 | |
Interest Coverage | 12.42 | 16.85 | 18.71 | 21.49 | 33.06 | 25.67 | |
Capex To Operating Cash Flow | (0.28) | (0.31) | (0.26) | (0.35) | (1.74) | (1.66) | |
Pfcf Ratio | 35.13 | 34.28 | 46.5 | 71.71 | (166.48) | (158.15) | |
Days Payables Outstanding | 108.64 | 106.95 | 83.38 | 106.29 | 144.25 | 124.29 | |
Income Quality | 1.71 | 0.58 | 1.05 | 1.13 | 0.81 | 0.85 | |
Roe | 1.78 | 1.1 | 0.62 | 0.59 | 0.49 | 0.26 | |
Ev To Operating Cash Flow | 28.08 | 25.57 | 36.3 | 48.57 | 129.04 | 135.49 | |
Pe Ratio | 26.38 | 24.74 | 44.88 | 52.83 | 100.13 | 105.14 | |
Ev To Free Cash Flow | 39.0 | 37.17 | 48.93 | 74.79 | (173.59) | (164.91) | |
Earnings Yield | 0.0379 | 0.0404 | 0.0223 | 0.0189 | 0.009987 | 0.009487 | |
Net Debt To E B I T D A | 0.31 | 2.04 | 1.69 | 1.5 | 1.8 | 1.89 | |
Current Ratio | 1.73 | 1.16 | 1.4 | 1.23 | 1.05 | 0.94 | |
Tangible Book Value Per Share | (8.16) | (5.94) | (2.68) | (0.56) | (1.09) | (1.04) | |
Receivables Turnover | 4.03 | 3.54 | 3.48 | 3.33 | 3.01 | 5.41 |
Eli Lilly Investors Sentiment
The influence of Eli Lilly's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Eli. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Eli Lilly's public news can be used to forecast risks associated with an investment in Eli. The trend in average sentiment can be used to explain how an investor holding Eli can time the market purely based on public headlines and social activities around Eli Lilly and. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Eli Lilly's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Eli Lilly's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Eli Lilly's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Eli Lilly.
Eli Lilly Implied Volatility | 49.78 |
Eli Lilly's implied volatility exposes the market's sentiment of Eli Lilly and stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Eli Lilly's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Eli Lilly stock will not fluctuate a lot when Eli Lilly's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eli Lilly in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eli Lilly's short interest history, or implied volatility extrapolated from Eli Lilly options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Eli Stock analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.13 | Dividend Share 4.52 | Earnings Share 5.82 | Revenue Per Share 37.908 | Quarterly Revenue Growth 0.281 |
The market value of Eli Lilly is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.